Mo1351: VONOPRAZAN IN THE CONTROL OF ESOPHAGEAL ACID EXPOSURE, MUCOSAL HEALING, AND SYMPTOM RELIEF IN PATIENTS WITH ESOPHAGITIS: EXPECTED ONSET TIME FROM A MULTICENTER STUDY USING 96-HOUR WIRELESS PH MONITORING CAPSULES
Xuelian Xiang(Guangxi Medical University), Xiaohua Hou(Wuhan Union Hospital), Tao Bai(Huazhong University of Science and Technology), Dongke Wang(Union Hospital), Nina Zhang(Nanjing Drum Tower Hospital), Liangliang Shi(Tianjin University of Traditional Chinese Medicine), Jun Song, Xiaohao Zhang(China University of Geosciences (Beijing)), Junying Xu(Wuxi People's Hospital)
Cited by 0
Related Papers
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|268
Chinese Consensus Report on Family-Based<i>Helicobacter pylori</i>Infection Control and Management (2021 Edition)
|Gut|2021|183
Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency
|Journal of Biomedical Science|2021|151
Diversity of Duodenal and Rectal Microbiota in Biopsy Tissues and Luminal Contents in Healthy Volunteers
|Journal of Microbiology and Biotechnology|2015|140
Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside
|Journal of Neurogastroenterology and Motility|2016|134